BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions
Teva (TEVA) Takes Small Mylan (MYL) Stake in Hostile Move 5/28/2015
Does Gilead (GILD)'s Hepatitis B Failure Mean More M&A? 5/28/2015
Pfizer (PFE)'s New York Campus May Have a Buyer 5/28/2015
Padlock Therapeutics Snatches Up Some GlaxoSmithKline (GSK) Scraps for Undisclosed Sum 5/28/2015
Retrophin (RTRX) Banks $245 Million From Sanofi (SAN.PA) for Priority Review Voucher 5/27/2015
Youbo Pharma Acquired By Jiuzhitang In $1 Billion Reverse Takeover 5/27/2015
Mylan (MYL) CEO Says Pfizer (PFE) Should Come Calling, As Next Big Deal Speculation Swirls 5/26/2015
ErgoMed Acquires Medical Information Service Provider 5/26/2015
Pfizer (PFE) Will Make $120 Billion Bid for GlaxoSmithKline (GSK) in Third Quarter, Says Poll 5/26/2015
AbbVie (ABBV) Completes Acquisition Of Pharmacyclics (PCYC) 5/26/2015
IntelliPharmaCeutics Buys Property That Houses R&D & Office in Toronto, Ontario 5/26/2015
PhytoTech Medical Limited (ASX:PYL) PYL-MMJ Merger Update 5/26/2015
Tanner Pharmaceuticals, BurnsAdler Pharmaceuticals, Inc. Merge To Form Tanner Pharma Group 5/26/2015
As Market Roars, Gilead (GILD) Looking for "Value-Added" Deals, Says CFO 5/22/2015
Valeant (VRX) Chief Calls Recent Biotech M&A "Bit of a Bubble" 5/22/2015
Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline (GSK) and Pfizer (PFE) 5/22/2015
Novartis Pharma AG (NVS) Unloads Certain Specialty Product Rights to Merus for $29.5 Million 5/22/2015
AbbVie (ABBV) Announces Expiration Of Hart-Scott-Rodino Waiting Period AbbVie's Acquisition Of Pharmacyclics (PCYC) 5/22/2015
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, And WuXi PharmaTech Co., Ltd. To Jointly Acquire U.S. Innovative Biotechnology Company Ambrx, Inc. 5/22/2015
Lannett (LCI) Snaps Up Competitor Silarx for $42 Million, As Dealmaking Booms 5/21/2015
Strides Arcolab Limited Ponies Up $299.90 Million for Aspen Pharmacare's Drug Brands 5/21/2015
AbbVie (ABBV) Announces Offer Consideration For Acquisition Of Pharmacyclics (PCYC) 5/21/2015
Cadila Close to Buying Rival CLARIS Lifesciences for About $534 Million: Report 5/21/2015
Valeant (VRX) in Talks to Pay $700 to $800 Million for Egyptian Drugmaker Amoun to Expand GI Line 5/20/2015
Twitter Attempts to Marry Gilead (GILD), Achillion (ACHN), Finds Reality Instead 5/20/2015
New York's Kinex Expected to Hire 80 to 240 Immediately, 800 Over Next Two Years 5/20/2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015
Is Bayer (BAY) Eyeing Sirtex Medical (SRX.AX)? 5/19/2015
Ipsen (IPN.PA) Strengthens Its Presence In The Oncology Field With The Acquisition Of Octreopharm Sciences, A Company Developing Innovative Radiopharmaceuticals For The Diagnosis And Treatment Of Neuroendocrine Tumors 5/19/2015
Pharmaxis (PXS.AX) Shares Catapult on $750 Million Liver Drug Sale to Boehringer Ingelheim 5/18/2015
Endo Pharmaceuticals (ENDP) Continues Expansion With $8.05 Billion Acquisition of Par Pharma 5/18/2015
Mylan (MYL) Chairman Tells Investors He Would Consider Buying Rival Teva (TEVA) 5/18/2015
Here's Why Gilead (GILD) Should Avoid Bigger Deals and Focus on Smaller Cancer-Focused Buyouts 5/18/2015
How GlaxoSmithKline (GSK)'s Much-Criticized Chief's Strategy Differs From His Peers 5/18/2015
Patrick Soon-Shiong's NantPharma Snaps Up Rights to Sorrento's Cynviloq in Deal Worth $1.3 Billion+ 5/18/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/18/2015
Lannett Company, Inc. (LCI) Signs Definitive Agreement To Acquire Silarx Pharmaceuticals, Inc. 5/18/2015
Boehringer Ingelheim Acquires Pharmaxis (PXS.AX)’ Phase 1 Anti-Inflammatory Drug Candidate 5/18/2015
ADM Grows Sweetener Business In China With Agreement To Purchase Meiweiyuan Biotechnology 5/18/2015
Circassia (CIR.L) Drops $377 Million for Two Asthma Firms, Aerocrine and Prosonix 5/15/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/15/2015
Hospira Shareholders Approve Merger Of Hospira And Pfizer (PFE) At Special Meeting 5/14/2015
Targacept (TRGT) And Catalyst Biosciences Amend Definitive Merger Agreement 5/14/2015
Pfizer (PFE) Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira 5/14/2015
ULURU Inc. Announces The Acquisition Of Altrazeal Trading GmbH 5/14/2015
BayBio and CHI Merge, Making California Life Sciences Association the Largest Life Sciences Advocacy Group in U.S. 5/14/2015
Affymetrix (Santa Clara, California) (AFFX) Scoops Up Eureka Genomics's Assets for $15 Million Cash 5/14/2015
White-Hot Juno Therapeutics (JUNO) Goes Shopping Again, Shelling Out $81 Million for Stage Cell Therapeutics 5/13/2015
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff 5/13/2015
ANI Pharmaceuticals, Inc. Acquires Rights To Testosterone Gel 1% 5/13/2015
Siegfried: RAG -Stiftung Beteiligungsgesellschaft mBH To Participate In Financing Of Latest Acquisition 5/13/2015
Pfizer (PFE) Pays $87.5 Million for Stake in AM-Pharma, With Option to Swallow Entire Company 5/12/2015
Santen Pharmaceutical Announces Assignment Of Its Anti-Rheumatic Pharmaceuticals Business To Hyperion Pharma 5/12/2015
Perrigo (PRGO) Acquires Patheon (PTI.TO)'s Mexican Operations for $34 Million Cash 5/12/2015
Endo Pharmaceuticals (ENDP) Shells Out $130 Million for Nearly 70 Pipeline Programs From Aspen Pharmacare 5/11/2015
Yew Bio-Pharm Group Signs The Tripartite Joint Planting Auricularia Auricula Contract And Acquires Financial Supporting From BiCOM 5/11/2015
Ligand Pharmaceuticals Inc. (LGND) Acquires Rights To More Than 15 Fully-Funded Development Programs From Selexis SA 5/11/2015
ERT Completes Acquisition Of PHT Corporation 5/11/2015
Abbott (ABT) May Be Hunting for M&A With Cash Reaped From Mylan (MYL)'s Three-Way Tussle 5/8/2015
Gilead (GILD) Finally Spends Some Money With $65 Million Buy 5/8/2015
Syngenta AG (SYT) Rejects $45 Billion Takeover Offer From Monsanto Company (MON) 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Opko Health (OPK) Snaps Up EirGen for $135 Million 5/7/2015
Siegfried Pays $306 Million For BASF's Drug Ingredient Businesses 5/7/2015
Horizon Pharma (HZNP) Completes Acquisition Of Hyperion Therapeutics (HPTX) 5/7/2015
Alexion (ALXN) Plunks Down $8.4 Billion for Synageva BioPharma (GEVA), As Dealmaking Roars 5/7/2015
Cipher Pharma (DND.TO) Acquires Canadian Commercialization Rights To Vaniqa And Actikerall 5/6/2015
ECUPHAR Enters The Spanish And Southern European Markets Through ESTEVE 5/6/2015
Guizhou Xinbang Pharma Buys Hangzhou Chinese Peptide For $323 Million 5/6/2015
IBM (IBM) Closes Acquisition Of Phytel 5/5/2015
Renmatix Accelerates Commercial Progress With Acquisition Of Former Mascoma Production Unit 5/5/2015
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015
Pfizer (PFE) Confirmed to be Mystery Bidder of $4.3 Billion Sobi 5/4/2015
A Profitable Q1 Leaves Gilead (GILD) CEO Money to Go Shopping for Possible M&As 5/4/2015
OphthaliX Inc. Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
HEALTHSOUTH Completes Purchase Of Cardinal Hill Rehabilitation Hospital In Lexington, Kentucky 5/4/2015
Can-Fite BioPharma (CFBI) Subsidiary, OphthaliX, Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 5/4/2015
Agilent Technologies Inc. (A) To Acquire Cartagenia n.v., Leading Provider Of Software To Enable Clinical Analysis Of Genomics Data 5/4/2015
Braeburn Pharmaceutical Expands Pipeline To Include Schizophrenia With Endo Pharmaceuticals (ENDP) Deal 5/1/2015
Sorrento Therapeutics, Inc. Acquires South American Rights To Cynviloq 5/1/2015
Omnicell Increases U.K. Commitment And Presence With Acquisition Of Longtime Partner Avantec Healthcare Limited 4/30/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Share Purchase Agreement With Lincoln Park Capital Fund, LLC 4/30/2015
Horizon Pharma (HZNP) Announces Expiration Of HSR Waiting Period For Proposed Hyperion Therapeutics (HPTX) Acquisition 4/30/2015
Why a Gilead (GILD)/Vertex (VRTX) Deal Makes More and More Sense 4/29/2015
Will Pfizer (PFE) Make a Play for Struggling GlaxoSmithKline (GSK)? 4/29/2015
Perrigo (PRGO) Sends Mylan (MYL) Back to the Drawing Board After Rejecting Second, Higher Bid 4/29/2015
Mylan (MYL) Ups Bid for Perrigo (PRGO) to $32.7B, As M&A Hungry Hippos Continues 4/29/2015
Medican Enterprises Signs Definitive Purchase Agreement To Acquire CBD Branding Company TWYNS For All Stock Transaction 4/28/2015
Celgene (CELG) Picks Up San Francisco Biotech Quanticel in $485 Million Deal 4/28/2015
Resverlogix (RVX.TO) CEO Says It's in Talks With Suitors, After $100M in Q1 Deals 4/28/2015
In Testy Letter to Teva (TEVA)'s CEO, Mylan (MYL) Rejects Its $40B Bid, Questions Credibility 4/28/2015
Sobi Waves For Sale Sign at Big Pharmas Like Pfizer (PFE), Biogen (BIIB) 4/27/2015
Could Google (GOOG) Be a Buyer for Former Merck & Co. (MRK) HQ? 4/27/2015
Small Biotech Clovis Oncology (CLVS)'s Breakthrough Drugs May Catch the Eye of Pfizer (PFE), Roche (RHHBY) 4/27/2015
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share 4/27/2015
R-Tech Ueno: Announcement On Acquisition Of The Right To Develop And Commercialize DE-105 From Santen Pharmaceutical 4/27/2015
Pernix (PTX) Closes Acquisition Of Zohydro ER Franchise 4/27/2015
Karo Bio AB Closes Acquisition Of Product For Treatment Of Common Cold Through A Directed Issue 4/27/2015
Why Ariad (ARIA) Could Be Worth $3 Billion to a Big Drugmaker 4/24/2015
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion 4/24/2015
T-Bird Pharma Inc. Announces Closing Of Transaction With Medna Biosciences 4/24/2015
Zogenix (ZGNX) Closes Sale Of Zohydro ER Business To Pernix (PTX) 4/24/2015
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again 4/23/2015
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL) 4/23/2015
Teva (TEVA) Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Mylan (MYL) 4/22/2015
Roche (RHHBY) CEO Not Interested in Megamergers, Only New Products and Technologies 4/22/2015
DuPont (DD) Acquires Taxon Biosciences, Inc. 4/22/2015
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015 4/21/2015
BREAKING: Perrigo (PRGO) Rejects $30B Mylan (MYL) Bid, Says Deal "Substantially Undervalues" Irish Firm 4/21/2015
Tartan Holdings, LLC Acquires Real Estate And Assets From Moog Inc.; Launches iuvo Bioscience 4/21/2015
Actelion Ltd. (ALIOF.PK) CFO Actively Hunting for M&A Opportunities 4/21/2015
Concordia Healthcare (CXR.TO) Announces Completion Of Acquisition Of Covis Pharma Commercial Assets For U.S. $1.2 Billion 4/21/2015
Omnicell Closes Acquisition Of Germany-Based MACH4 Pharma Systems 4/21/2015
Daiichi Sankyo Dumps $3.6 Billion Sun Pharma (SUNPHARMA.NS) Stake 4/20/2015
Teva (TEVA) Will Bid For Mylan (MYL), Say Sources, As Tug-of-War Continues 4/20/2015
AbbVie (ABBV) Extends Exchange Offer To Acquire Pharmacyclics (PCYC) 4/20/2015
Intrexon Corporation Completes Acquisition Of Okanagan Specialty Fruits 4/20/2015
Agilent Technologies Inc. (A) Recommends Stockholders Reject TRC Capital’s “Mini-Tender” Offer 4/20/2015
Mallinckrodt (MNK) Completes Acquisition Of Ikaria 4/17/2015
Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource 4/17/2015
As Proxy Fight Continues, Five Companies That May be Eyeing Ariad (ARIA) 4/16/2015
Three Biotechs Well-Positioned for M&A: Gilead (GILD), Celgene (CELG), and Biogen (BIIB) 4/16/2015
LGC Acquires Biosearch Technologies And Extends Its Expertise In The qRCR Market 4/15/2015
Is Johnson & Johnson (JNJ) Eyeing Large M&As? 4/15/2015
Talent Exodus From Banks Continues as Healthcare M&A Thrives 4/14/2015
Roche (RHHBY) Grabs CAPP Medical, a "Liquid Biopsy" Startup Targeting Cancer 4/14/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/14/2015
Merck & Co. (MRK) Still Trying to Squeeze Out Worth From $50 Billion Schering-Plough (SGP) Buyout 4/13/2015
Mylan (MYL) Notifies Perrigo Company (PRGO) Of HSR Filing Regarding Proposed Acquisition 4/13/2015
Recro Pharma (REPH) Completes Acquisition Of IV/IM Meloxicam And CGMP Manufacturing Facility And Business Unit From Alkermes (ALKS) 4/13/2015
Accovion Signs Agreement To Be Acquired By Clinipace Worldwide 4/13/2015
Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals and Nutritionals ("APN") Creating A Top Tiered Global OTC Pharmaceutical and Nutraceutical Company 4/13/2015
Cipher Pharma (DND.TO) Nabs INNOCTIS and Experienced U.S. Sales Force for $45 Million Cash 4/13/2015
The Inside Story Behind Cellular Dynamics’ $307 Million Sale To FUJIFILM 4/10/2015
Karo Bio AB Acquires Product For Treatment Of Common Cold 4/10/2015
Mylan (MYL) Proposes To Acquire Perrigo (PRGO) For $205 Per Share 4/9/2015
Bristol-Myers Squibb (BMY) Completes Previously Announced Acquisition Of Flexus Biosciences 4/8/2015
Agenus (AGEN) Acquires Celexion Assets And Expands Its Antibody Discovery Platform 4/8/2015
Panther Biotechnology Announces Agreement To Acquire Technology Assets Of Faulk Pharmaceuticals 4/7/2015
SoCal's Receptos (RCPT) Seeks Partnerships But Gains Takeover Interest Instead 4/3/2015
Janssen Pharmaceutical Completes Divestiture Of U.S. License Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended-Release Tablets And NUCYNTA (tapentadol) Oral Solution To Depomed, Inc. (DEPO) 4/3/2015
Depomed, Inc. (DEPO) Announces Closing Of Acquisition Of U.S. Rights To NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) Extended Release Tablets And NUCYNTA (tapentadol) Oral Solution From Janssen Pharmaceutical For $1.05 Billion 4/3/2015
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 4/2/2015
With A Few Short Words, Salix (SLXP) As A Company Disappears 4/2/2015
Former Allergan (AGN) CEO Pyott Sees $534M Cash Payday After Stock Sale 4/2/2015
Daiichi Sankyo Cuts-and-Pastes for 5-Year Plan: Sister Companies Daiichi Sankyo, Inc. (DSNKY) and Asubio Pharma Co., Ltd. Merge 4/1/2015
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India 4/1/2015
Infinity Pharmaceuticals Inc. (INFI) Shells Out $52.5M to Purchase Cancer Drug Royalties From Takeda (TKPYY) 4/1/2015
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/31/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015
Japan's FUJIFILM to Acquire U.S. Cellular Dynamics for $307M 3/31/2015
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/31/2015
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015
FUJIFILM To Acquire Cellular Dynamics 3/30/2015
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 3/30/2015
Columbia Laboratories, Inc. (CBRX) Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 3/30/2015
Perrigo Company (PRGO) Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3/30/2015
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015
Synergy Pharmaceuticals May Be for Sale 3/27/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
Karolinska Development AB Sells Its Stake In Axelar To Östersjöstiftelsen 3/27/2015
FSC Laboratories To Market Cefaclor For Oral Suspension In The U.S. 3/26/2015
PAREXEL International (PRXL) Announces Execution Of Definitive Agreement To Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3/26/2015
Salix (SLXP) Had a $13 Billion Offer on the Table From Allergan (AGN) Before Accounting Problems Smashed Share Price 3/25/2015
Sun Pharma (SUNPHARMA.NS) Announces Closure Of Merger Deal With Ranbaxy 3/25/2015
Life Post-Ranbaxy Laboratories (RANBAXY.BO)? Sun Pharma (SUNPHARMA.NS) Holds On to $300 Million and Hunts for More M&As 3/25/2015
APR Applied Pharma Research S.A. Today Announced That HBM Partners AG (“HBM”) Has Acquired A Minority Stake In APR 3/25/2015
Accellta Grants Exclusive Rights for Micro-Carrier Free Stem Cells Suspension Culture To StemCell Technologies Inc. 3/24/2015
Bristol-Myers Squibb (BMY) Acquires Exclusive License From Novo Nordisk A/S (NVO) For A Discovery Research Program Focused On Autoimmune Diseases 3/24/2015
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates 3/24/2015
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/23/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis 3/23/2015
Biophage Pharma Inc. Announces The Conclusion Of A Conditional Asset Purchase Agreement 3/23/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout 3/20/2015
Johnson & Johnson (JNJ)'s Janssen Pharmaceutical Snaps Up Virtual Biopharma XO1 Limited for Hush Hush Price 3/19/2015
Tyme Technologies Completes Reverse Merger 3/19/2015
Heraeus Medical Components Enters Agreement To Acquire NeoMetrics 3/19/2015
Prestium Pharma Acquires ZONALON (Doxepin Hydrochloride), 5% Cream; Continues To Expand Its Product Portfolio 3/19/2015
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015
Depomed, Inc. (DEPO) Announces Termination Of Hart-Scott-Rodino Waiting Period For Pending Acquisition Of NUCYNTA Franchise From Janssen Pharmaceutical Inc. 3/17/2015
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015
Kite Pharma (KITE) Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition Of T-Cell Factory B.V. (TCF) 3/17/2015
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015
European Commission (EC) Clears Actavis (ACT)' Pending Acquisition Of Allergan (AGN) 3/16/2015
Ruthigen And Pulmatrix Enter Into Merger Agreement 3/16/2015
Salix (SLXP) Sale Could Mean 220 Job Losses, But There is a Silver Lining 3/13/2015
GlaxoSmithKline (GSK) Pockets $853 Million by Halving Stake in Aspen Pharmacare 3/13/2015
Employees at Three Major Biopharmas Remain Uncertain, As Salix (SLXP) Confirms Bid From Endo International (ENDP) 3/13/2015
Porton Fine Chemicals Pays $41.5 Million To Acquire Dongbang Pharma 3/12/2015
LMC Diabetes & Endocrinology And Manna Research Merge Research Programs 3/12/2015
Salix (SLXP) Confirms Receipt Of An Unsolicited Proposal From Endo International (ENDP) 3/12/2015
Ember Therapeutics And Mariel Therapeutics Enter Definitive Merger Agreement Creating A Strong Diversified Company 3/12/2015
Epizyme (EPZM) Reacquires Rights to Cancer Drug From Eisai Company (ESALY.PK) in Deal Worth $110 Million 3/12/2015
Mounting Hospira Recalls and Plant Woes Will Soon be Pfizer (PFE)'s Problem 3/12/2015